Purchase Order 12805B19P0035
- Not listed
- The U.S. Department of Agriculture's Plains Area office awarded a $27,232.58 firm fixed-price purchase order to Lampire Biological Labs Inc. for sheep defibrinated blood donor materials. The contract was awarded on February 19, 2020, with an ultimate completion date of February 18, 2025, and does not utilize a set-aside designation. The work will be performed in Manhattan, Kansas. Lampire Biological Labs Inc., a Pennsylvania-based manufacturer specializing in animal-derived blood and tissue...
- The U.S. Department of Agriculture (USDA) Agricultural Research Service awarded a $25,740.00 firm fixed price purchase order to Lampire Biological Labs Inc., a small business manufacturer, for the delivery of sheep blood to support research at the USDA's Manhattan, Kansas facility. This award is the result of a small business set-aside solicitation for weekly shipments of 100ml of defibrinated sheep blood over a base period of one year, with four one-year option periods. The blood will be used...
- The U.S. government awarded a delivery order valued at $3,552.62 to Lampire Biological Labs Inc. for the provision of blood products derived from horses and sheep. This contract, awarded on May 11, 2016, with an ultimate completion date of September 27, 2017, was designated as a Total Small Business set-aside and funded through the Office of Administrative Services Procurement Management Branch. The contract employs firm fixed price pricing and specifies St. Louis, Missouri as the place of...
- The U.S. General Services Administration awarded a delivery order valued at $2,320.75 to Lampire Biological Labs Inc. for the supply of horse and sheep blood under the parent contract 123A9418D0003. The award was made without a set-aside designation on August 9, 2018, with a completion date of January 27, 2020. Performance was scheduled to take place in St. Louis, Missouri, and specific delivery amounts and dates were outlined in an attached schedule. The contract utilized firm fixed pricing and...
- This federal contract award was made by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Lampire Biological Labs Inc., a for-profit manufacturer of various blood products for research, diagnostic, and therapeutic applications. The $29,520 firm fixed price purchase order is for the provision of porcine (pig) blood, and does not have a set-aside designation. The contract has a completion date of September 27, 2016. Lampire Biological Labs Inc. has received...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $4,888.00 firm fixed price purchase order to Lampire Biological Labs Inc., a for-profit manufacturer, to provide weekly shipments of red turkey blood cells for 52 weeks. This award was set aside for small businesses. Lampire Biological Labs Inc. is a manufacturer that specializes in custom antibodies, blood products, tissues, organs, and reagents for research,...
- This federal contract award, valued at $70,080.00, was issued by the Defense Health Agency (DHA) to Lampire Biological Labs Inc., a for-profit manufacturer of biological products located in Ottsville, Pennsylvania. The contract is for the provision of 50 ml of defibrinated rabbit blood to support research at the Walter Reed Army Institute of Research (WRAIR). The contract was awarded on a sole-source basis under simplified acquisition procedures, as Lampire Biological Labs was determined to be...
- The Defense Logistics Agency Troop Support Medical awarded a $76,670 delivery order contract to Fisher Scientific Company L.L.C. for sheep whole blood and sheep blood alsevers. The prime contractor is a subsidiary of Thermo Electron Corporation Financial Services Division and will perform the work in Pittsburgh, Pennsylvania between August 22nd and September 6th, 2023. The contract utilizes a fixed price with economic price adjustment pricing structure. No set aside designation or subcontractors...
- The Defense Logistics Agency Troop Support Medical awarded a $228,960 delivery order to Fisher Scientific Company L.L.C. for 100mL bottles of sheep blood defibrinated. The prime contractor, a subsidiary of Thermo Electron Corporation, will deliver the product from its facility in Pittsburgh, Pennsylvania between July 20-27, 2023. The fixed price with economic price adjustment contract was awarded utilizing the Medical Prime Vendor program, a strategic sourcing initiative managed by DLA Troop...
- Jennings Joshua C. was awarded a firm fixed price purchase order by the United States Department of Agriculture Agricultural Research Service Field Research Implementation and Information Delivery. The contract is for the supply of bovine blood products, specifically citrated and defibrinated bovine blood, to support the agency's research efforts. The potential value of the contract is $152,360. Performance will occur in Gainesville, Florida and be completed by January 31, 2027. No set aside...
The U.S. Department of Agriculture's Plains Area office awarded a $3,496 firm fixed-price purchase order to Lampire Biological Labs Inc. for sheep blood on December 18, 2018, with completion scheduled for December 31, 2019. This civilian contract, placed without set-aside designation, supports agricultural research activities at the Manhattan, Kansas location. Lampire Biological Labs Inc., a Pennsylvania-based manufacturer of animal-derived biological products, has served as a critical supplier to multiple federal agencies including the USDA Agricultural Research Service, Centers for Disease Control and Prevention, and the National Institutes of Health since its registration in the System for Award Management in 2002. This sheep blood procurement reflects the company's specialized capability in providing processed biological materials essential for federal research and diagnostic applications. Lampire's established track record includes significant contracts across the federal government, most notably a $100 million Blanket Purchase Agreement with the National Institutes of Health effective through April 2025, which demonstrates the company's comprehensive capacity to supply tissue, cell culture, animal serum, and blood products to support government research initiatives. The current award represents a routine procurement within the company's broader portfolio of federal biological products supply agreements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($40) | 4/7/20 | |
| Not listed | Not listed | $3.5k | 12/19/18 |